On Point Advisor's  Instablog

acetaminophen, Ackman, Acquisitions, ACT, adulterated products, Allegra, Alli, antitussives, Arthritis supplements, asthma, Banana Boat, Bayer, Ben Gay, Benadryl, Boehringer Ingelheim, brand equity, Bullfrog, celebrities, Chattem, Ciba, colds, consent decree, consumer healthcare products, Coppertone, cough, CPC, Crest, Dayquil, denture adhesives, destocking, Dexatrim, Dial, Dieting, diphenhydramine, doxepin, drugs, endorsement, Excedrin-PM, FDA, Fixodent, Flector, flu, Glaxo, H1N1, health care, healthcare, Healthcare, Henkel, Hisamitsu, ibuprofen,

Icy Hot, influenza, IRS, Lec Tec, LecTec, liability, Lidoderm, lipsitch, Listerine, Marinomed, Matrixx, McDonald, McNeil, mergers, mouthwash, News Alerts, non-prescription drugs, Noven, Noxzema, Nyquil, Obama, Obamacare, Olay, orlistat, OsteoBiflex, OTC, pain, pain patch, pandemic, patches, Pershing Square, plant shut downs, Poligrip, Precise, prescriptions, Prevacid, Pro-Health, product recall, promotion, Propel, Purell, quality, recall, Recalls, Roche, Salonpas, Sanofi, Silensor, Sinex, sleep,

Somaxon, sprays, sunscreens, takeovers, tax, Total, Tylenol, Tylenol-PM, Vicks, warning letter, weight loss, Wellpatch, Xenical, Zicam, zinc